Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Amortizatization of Intangibles (2024 - 2025)

Connect Biopharma Holdings' Amortizatization of Intangibles history spans 2 years, with the latest figure at $169000.0 for Q3 2025.

  • For Q3 2025, Amortizatization of Intangibles changed N/A year-over-year to $169000.0; the TTM value through Sep 2025 reached $730000.0, changed N/A, while the annual FY2024 figure was $123000.0, 92.78% down from the prior year.
  • Amortizatization of Intangibles for Q3 2025 was $169000.0 at Connect Biopharma Holdings, down from $288000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $288000.0 in Q2 2025 and bottomed at $10000.0 in Q2 2024.